Evidence map›Paper›PMID 39613907›Full record

ArticleInsights into imaging2024

Machine learning-based radiomics prognostic model for patients with proximal esophageal cancer after definitive chemoradiotherapy.

Linrui Li, Zhihui Qin, Juan Bo, Jiaru Hu, Yu Zhang, Liting Qian, Jiangning Dong

Abstract read
In one paragraph

Article in Insights into imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Linrui LiDepartment of Radiation Oncology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, China.
Zhihui QinDepartment of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Juan BoDepartment of Radiation Oncology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, China.
Jiaru HuDepartment of Radiation Oncology, West Branch of the First Affiliated Hospital of University of Science and Technology of China, Hefei, China.
Yu ZhangDepartment of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. zhangyu199831@163.com.
Liting QianDepartment of Radiation Oncology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, China. money2004@sina.com.
Jiangning DongDepartment of Radiation Oncology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, China. dongjn@163.com.ORCID http://orcid.org/0000-0002-2954-076X

Funding

Anhui Province 2023 provincial financial support key project AHWJ2023A10102
6 · The paper itself

Abstract

objectivesTo explore the role of radiomics in predicting the prognosis of proximal esophageal cancer and to investigate the biological underpinning of radiomics in identifying different prognoses.

methodsA total of 170 patients with pathologically and endoscopically confirmed proximal esophageal cancer from two centers were enrolled. Radiomics models were established by five machine learning approaches. The optimal radiomics model was selected using receiver operating curve analysis. Bioinformatics methods were applied to explore the potential biological mechanisms. Nomograms based on radiomics and clinical-radiomics features were constructed and assessed by receiver operating characteristics, calibration, and decision curve analyses net reclassification improvement, and integrated discrimination improvement evaluations.

resultsThe peritumoral models performed well with the majority of classifiers in the training and validation sets, with the dual-region radiomics model showing the highest integrated area under the curve values of 0.9763 and 0.9471, respectively, and outperforming the single-region models. The clinical-radiomics nomogram showed better predictive performance than the clinical nomogram, with a net reclassification improvement of 34.4% (p = 0.02) and integrated discrimination improvement of 10% (p = 0.007). Gene ontology enrichment analysis revealed that lipid metabolism-related functions are potentially crucial in the process by which the radiomics score could stratify patients.

conclusionsA combination of peritumoral radiomics features could improve the predictive performance of intratumoral radiomics to estimate overall survival after definitive chemoradiotherapy in patients with proximal esophageal cancer. Radiomics features could provide insights into the lipid metabolism associated with radioresistance and hold great potential to guide personalized care. CRITICAL RELEVANCE STATEMENT: This study demonstrates that incorporating peritumoral radiomics features enhances the predictive accuracy of overall survival in proximal esophageal cancer patients after chemoradiotherapy, and suggests a link between radiomics and lipid metabolism in radioresistance, highlighting its potential for personalized treatment strategies. KEY POINTS: Peritumoral region radiomics features could predict the prognosis of proximal esophageal cancer. Dual-region radiomics features showed significantly better predictive performance. Radiomics features can provide insights into the lipid metabolism associated with radioresistance.

Indexed as

Machine learningProximal esophageal cancerRadiomicsTumor microenvironment

Identifiers

PMID39613907
PMCPMC11607220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.